Results 91 to 100 of about 31,662 (260)

GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma

Cell Communication and Signaling
Background While previous studies have primarily focused on Glucose transporter type 1 (GLUT1) related glucose metabolism signaling, we aim to discover if GLUT1 promotes tumor progression through a non-metabolic pathway.
Zhiqing Zhou, Yu Li, Sijie Chen, Zhangrong Xie, Yuhui Du, Yue Liu, Yuxuan Shi, Xiangyi Lin, Xiaofei Zeng, Huijie Zhao, Guoan Chen   +10 more
doaj   +1 more source

GLUT1 Expression in Oral Squamous Cell Carcinoma and Its Significance [PDF]

Middle East Journal of Cancer
Background: GLUT1, a glucose transport protein, exhibits heightened expression in malignant cells, leading to increased glucose absorption. The detection of GLUT1 through immunohistochemical methods in these cancerous cells suggests elevated rates of ...
Aayisha Neloufar Mohamed Haneef, Sivakumar Gopalakrishnan, Vijayashree Jayaseelan, Raghini Ramamurthi, Sivakumar Muniapillai   +4 more
doaj   +1 more source

Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin [PDF]

, 1994
James F. Clarke, Paul Young, Kazuyoshi Yonezawa, Masato Kasuga, Geoffrey D. Holman   +4 more
openalex   +1 more source

Ketogenic diet therapy for epilepsy during pregnancy and lactation: An international survey exploring clinician perspectives

Epilepsia Open, EarlyView.
Abstract Objective Ketogenic diet therapies (KDTs) are increasingly used as a treatment for people with epilepsy of childbearing potential (PWECP) and glucose transporter type 1 deficiency syndrome (Glut1DS). The aim of this study was to collect information on clinical experience with KDT during pregnancy and lactation in these populations.
Kelly Faltersack, Tanya J. W. McDonald, Valentina De Giorgis, Bobbie Barron, Mackenzie C. Cervenka, Anita Devlin, Laura A. Healy, Magnhild Kverneland, Elles van der Louw, Mengyang Lu, Martina P. Zanaboni, Marisa Armeno, Elizabeth A. Felton   +12 more
wiley   +1 more source

The role of N‐glycosylation in the targeting and stability of GLUT1 glucose transporter [PDF]

, 1993
Tomoichiro Asano, Kuniaki Takata, Hideki Katagiri, Hisamitsu Ishihara, Kouichi Inukai, Motonobu Anai, Hiroshi Hirano, Yoshio Yazaki, Yoshitomo Oka   +8 more
openalex   +1 more source

Alterations and mechanistic insights of gut microbiota and its metabolites in type 2 diabetes mellitus and Alzheimer's disease

iMetaOmics, EarlyView.
This narrative review uniquely addresses how gut microbiota‐derived metabolites mediate overlapping pathologies of insulin resistance, neuroinflammation, and amyloidogenesis in type 2 diabetes mellitus (T2DM) and Alzheimer's disease (AD), proposing a framework for dual therapeutic targeting.
Guangyi Xu, Yu An, Yage Du, Zhaoming Cao, Jie Zheng, Jingya Wang, Tingyi Li, Xingen Lei, Yanhui Lu   +8 more
wiley   +1 more source

Comparative evaluation of glucose transporter 1 expression in oral squamous cell carcinoma with and without cervical lymph node metastasis [PDF]

مجله پزشکی دانشگاه علوم پزشکی تبریز
Background. In addition to the local resection of the primary tumor, metastatic oral squamous cell carcinoma (OSCC) patients require neck lymph node resection.
Saeedeh Khalesi, Laleh Maleki, Parnia Mirzaee   +2 more
doaj   +1 more source

Kinetic resolution of the separate GLUT1 and GLUT4 glucose transport activities in 3T3-L1 cells [PDF]

, 1992
Robin Palfreyman, A E Clark, R. M. Denton, Geoffrey D. Holman, I J Kozka   +4 more
openalex   +1 more source

Optimising hypoxia PET imaging and its applications in guiding targeted radiation therapy for non‐small cell lung cancer: a scoping review

Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 106-118, March 2025.
This review article reports that quantification of hypoxic volumes using PET in the pre‐radiation therapy setting is of prognostic value and indicative of treatment response in non‐small cell lung cancer. Abstract Introduction Non‐small cell lung cancer (NSCLC) is the leading cause of cancer‐related death. Definitive treatment includes chemotherapy and
Carol Marks, Michelle Leech
wiley   +1 more source

Glucose transporter deficiency syndrome type 1: a case report

Русский журнал детской неврологии, 2019
The authors present a unique clinical observation of the case of a hereditary deficiency of a type 1 glucose transporter, also called de Vivo disease. The type 1 glucose transporter deficiency syndrome (OMIM: 606777, ORPHA: 71277) is an extremely rare ...
E. A. Kulish, A. S. Kotov, E. V. Mukhina, Y. Y. Kotalevskaya, D. V. Svetlichnaya, M. V. Panteleeva   +5 more
doaj   +1 more source